Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:HSM NYSE:PHM NASDAQ:TLT CVE:VPT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSMHelius Medical TechnologiesC$0.00C$14.26▼C$40.00C$42.54MN/A3,578 shs930 shsPHMPulteGroup$137.76+0.1%$121.69$104.04▼$144.49$26.21B1.21.74 million shs1.73 million shsTLTiShares 20+ Year Treasury Bond ETF$87.45+0.1%$85.69$82.77▼$92.18$43.52B0.5233.38 million shs19.45 million shsVPTVentriPoint DiagnosticsC$0.11C$0.13C$0.08▼C$0.19C$20.64M-0.454489128,746 shs46,500 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSMHelius Medical Technologies0.00%0.00%0.00%0.00%0.00%PHMPulteGroup0.00%+8.43%+16.36%+21.27%+30.49%TLTiShares 20+ Year Treasury Bond ETF0.00%+0.70%+1.87%+0.67%-0.03%VPTVentriPoint Diagnostics0.00%-8.33%-12.00%-4.35%-18.52%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSMHelius Medical TechnologiesC$0.00C$14.26▼C$40.00C$42.54MN/A3,578 shs930 shsPHMPulteGroup$137.76+0.1%$121.69$104.04▼$144.49$26.21B1.21.74 million shs1.73 million shsTLTiShares 20+ Year Treasury Bond ETF$87.45+0.1%$85.69$82.77▼$92.18$43.52B0.5233.38 million shs19.45 million shsVPTVentriPoint DiagnosticsC$0.11C$0.13C$0.08▼C$0.19C$20.64M-0.454489128,746 shs46,500 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSMHelius Medical Technologies0.00%0.00%0.00%0.00%0.00%PHMPulteGroup0.00%+8.43%+16.36%+21.27%+30.49%TLTiShares 20+ Year Treasury Bond ETF0.00%+0.70%+1.87%+0.67%-0.03%VPTVentriPoint Diagnostics0.00%-8.33%-12.00%-4.35%-18.52%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSMHelius Medical Technologies 0.00N/AN/AN/APHMPulteGroup 2.59Moderate Buy$140.712.15% UpsideTLTiShares 20+ Year Treasury Bond ETF 0.00N/AN/AN/AVPTVentriPoint Diagnostics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VPT, TLT, PHM, and HSM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/26/2026PHMPulteGroup OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform4/27/2026PHMPulteGroup Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B-) ➝ Hold (C)4/24/2026PHMPulteGroup UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$159.00 ➝ $162.004/24/2026PHMPulteGroup Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$132.00 ➝ $140.004/24/2026PHMPulteGroup EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$146.00 ➝ $151.004/24/2026PHMPulteGroup The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$133.00 ➝ $142.004/24/2026PHMPulteGroup CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$136.00 ➝ $138.004/20/2026PHMPulteGroup Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$145.00 ➝ $140.004/16/2026PHMPulteGroup Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$170.00 ➝ $150.004/13/2026PHMPulteGroup Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold(Data available from 6/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSMHelius Medical TechnologiesC$477K0.00N/A5.71C$3.61 per share0.00PHMPulteGroup$17.31B1.52$12.62 per share10.92$67.52 per share2.04TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/AN/AN/AN/AVPTVentriPoint DiagnosticsC$179.93K114.73C$0.02 per share5.53C($0.02) per share-4.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSMHelius Medical TechnologiesN/A-C$11.02N/AN/AN/AN/AN/AN/AN/APHMPulteGroup$2.22B$10.3413.3212.561.7512.14%16.41%11.75%7/22/2026 (Confirmed)TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/AN/AN/AN/AN/AN/AN/AVPTVentriPoint Diagnostics-C$5.25M-C$0.02N/AN/AN/A-1,778.62%78.25%-136.72%N/ALatest VPT, TLT, PHM, and HSM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2026Q2 2026PHMPulteGroup$2.38N/AN/AN/A$3.95 billionN/A4/23/2026Q1 2026PHMPulteGroup$1.80$1.79-$0.01$1.79$3.40 billion$3.41 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHSMHelius Medical TechnologiesN/AN/AN/AN/AN/APHMPulteGroup$1.040.76%+12.97%10.06%7 YearsTLTiShares 20+ Year Treasury Bond ETF$3.914.47%N/AN/AN/AVPTVentriPoint DiagnosticsN/AN/AN/AN/AN/ALatest VPT, TLT, PHM, and HSM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/29/2026PHMPulteGroupquarterly$0.260.83%6/16/20266/16/20267/2/20265/29/2026TLTiShares 20+ Year Treasury Bond ETFMonthly$0.33584.71%6/1/20266/1/20266/4/20264/30/2026TLTiShares 20+ Year Treasury Bond ETFMonthly$0.31535/1/20265/1/20265/6/20263/31/2026TLTiShares 20+ Year Treasury Bond ETFMonthly$0.34484.8%4/1/20264/1/20264/7/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSMHelius Medical Technologies0.744.203.58PHMPulteGroup0.140.940.94TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/AVPTVentriPoint Diagnostics-63.200.086.67Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSMHelius Medical TechnologiesN/APHMPulteGroup89.90%TLTiShares 20+ Year Treasury Bond ETF73.33%VPTVentriPoint Diagnostics4.06%Insider OwnershipCompanyInsider OwnershipHSMHelius Medical TechnologiesN/APHMPulteGroup0.75%TLTiShares 20+ Year Treasury Bond ETFN/AVPTVentriPoint Diagnostics2.13%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSMHelius Medical Technologies192.32 millionN/ANot OptionablePHMPulteGroup6,506190.49 million189.06 millionOptionableTLTiShares 20+ Year Treasury Bond ETFN/A497.60 millionN/AOptionableVPTVentriPoint Diagnostics147,000187.66 millionN/ANot OptionableVPT, TLT, PHM, and HSM HeadlinesRecent News About These CompaniesVentripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living With Heart DiseaseJune 26 at 5:32 PM | finance.yahoo.com16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart GapJune 17, 2026 | newswire.caCardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial FrontsMay 19, 2026 | tmcnet.comA Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in MedtechMay 13, 2026 | financialpost.comFA Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in MedtechMay 13, 2026 | markets.businessinsider.comThe $59B Quiet Shift Reshaping How Patients Access CareMay 12, 2026 | newswire.caWall Street's Cardiac Bet: Where Diagnostics Meet the MoneyMay 12, 2026 | newswire.caVentripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital CardiologyMay 4, 2026 | finance.yahoo.comWhy Medtech Giants Are Quietly Paying Up for AI DiagnosticsApril 29, 2026 | tmcnet.comThe Quiet Rule Change Tilting $10B Toward Medtech's Most Validated PlatformsApril 29, 2026 | tmcnet.comThe Infrastructure Play Hiding in Plain Sight Across Cardiac CareApril 16, 2026 | financialpost.comFThe Quiet Shift Replacing Million-Dollar Heart Scanners With SoftwareApril 16, 2026 | financialpost.comFVentriPoint Diagnostics Ltd.April 8, 2026 | marketwatch.comThe Hidden Crisis Driving Billions into Cardiac Care InnovationMarch 27, 2026 | baystreet.caVentripoint Taps LG Consulting to Drive VMS+ Rollout in Northern CaliforniaMarch 13, 2026 | theglobeandmail.com(CNW) Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve OutcomesMarch 4, 2026 | marketwatch.comHospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve OutcomesMarch 3, 2026 | tmcnet.comCEO.CA's Inside the Boardroom: Why Ventripoint is the Most Profitable "Bolt-On" Solution for Modern HospitalsFebruary 26, 2026 | finance.yahoo.comAI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural ShiftJanuary 29, 2026 | tmcnet.comAI Medical Imaging Revolution: Software-Native Tech Disrupts $45B MarketJanuary 27, 2026 | newswire.caNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026SpaceX Rings the Bell and Shatters Every RecordBy Jeffrey Neal Johnson | June 12, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 20263 Long-Duration Treasury ETFs to Watch if Rates FallBy Nathan Reiff | June 15, 2026The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on ItBy Chris Markoch | June 7, 2026VPT, TLT, PHM, and HSM Company DescriptionsHelius Medical Technologies TSE:HSMHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.PulteGroup NYSE:PHM$137.76 +0.15 (+0.11%) Closing price 03:59 PM EasternExtended Trading$137.90 +0.14 (+0.10%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PulteGroup, Inc., through its subsidiaries, primarily engages in the homebuilding business in the United States. It acquires and develops land primarily for residential purposes; and constructs housing on such land. The company also offers various home designs, including single-family detached, townhomes, condominiums, and duplexes under the Centex, Pulte Homes, Del Webb, DiVosta Homes, John Wieland Homes and Neighborhoods, and American West brand names. In addition, the company arranges financing through the origination of mortgage loans primarily for homebuyers; sells the servicing rights for the originated loans; and provides title insurance policies, and examination and closing services to homebuyers. PulteGroup, Inc. was founded in 1950 and is headquartered in Atlanta, Georgia.iShares 20+ Year Treasury Bond ETF NASDAQ:TLT$87.45 +0.09 (+0.10%) As of 04:00 PM EasterniShares 20+ Year Treasury Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of United States Treasury bonds with remaining maturities greater than 20 years. The Fund seeks to track the investment results of the Barclays U.S. 20+ Year Treasury Bond Index (the Underlying Index), which measures the performance of public obligations of the United States Treasury that have a remaining maturity of 20 or more years. The Underlying Index includes all publicly-issued the United States Treasury securities that have a remaining maturity of greater than or equal to 20 years. BlackRock Fund Advisors serves as investment adviser of the Fund.VentriPoint Diagnostics CVE:VPTC$0.11 0.00 (0.00%) As of 02:01 PM EasternVentripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The AI Boom Has a Second Act—And It's Playing Out in Optics Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback? 5 Tech Stocks to Buy on the July Pullback Is OpenAI’s IPO Delay a Warning for AI Investors? onsemi: What the Market Gets Wrong, You Can Get Right 5 Places Investors Can Hide If the AI Trade Keeps Cracking MarketBeat Week in Review – 06/22 - 06/26 Qualcomm’s Investor Day Just Changed the Growth Story Forever Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
